Larry Bressler, Head of Value and Market Access, Chiesi Global Rare Diseases
Matthias Breugelmans, CEO, Elastrin Therapeutics
Rusty Bromley, Director of Operations, AyuVis Research, Inc.
PJ Brooks, Health Scientist Administrator, NIH/NCATS
Robert Buchanan, Founder And Partner, Ventac Partners
Lynn Bush, Bioethicist-Developmental Research Scientist, Division of Genetics and Genomics, Pediatrics and Center for Bioethics, Harvard Medical School and Boston Children’s Hospital
Leonardo Calzetti, Co-founding Director & Sr. Partner, BlueDil International
Grant Castor, SVP Commercial Strategy & Operations, Sentynl Therapeutics
Ms Afshawn Chakamian, Director of Therapeutic Expertise, Center for Rare Diseases, DDS, ICON
Ms Anne-Sophie Chalandon, Head of Rare Diseases Global Public Affairs Rare Disease and ATMP Policy at Sanofi, Vice-Chair of the EFPIA OMP WG, Sanofi
Mr David Chapman, Vice President of Market Access, Agios Pharmaceuticals